We are live on ! Find out more
GCM

Glenview Capital Management Portfolio holdings

AUM $3.98B
1-Year Est. Return 20.52%
This Fund
S&P 500
This Quarter Est. Return
-13.27%
1 Year Est. Return
+20.52%
3 Year Est. Return
+68.18%
5 Year Est. Return
+87.14%
10 Year Est. Return
+400.35%
AUM
$4B
AUM Growth
-$942M
Cap. Flow
-$186M
Cap. Flow %
-4.65%
Top 10 Hldgs %
60.38%
Holding
66
New
6
Increased
24
Reduced
16
Closed
11

Top Buys

Rank Stock Value
1
CI icon
Cigna
CI
+$124M
2
MSFT icon
Microsoft
MSFT
+$55.7M
3
FMC icon
FMC
FMC
+$49.1M
4
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$40.7M
5
APTV icon
Aptiv
APTV
+$39.8M

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$212M
2
MTOR
MERITOR, Inc.
MTOR
+$126M
3
COR icon
Cencora
COR
+$116M
4
UHS icon
Universal Health Services
UHS
+$89.7M
5
MCK icon
McKesson
MCK
+$67.3M

Sector Composition

Rank Sector Weight
1 Healthcare 42.56%
2 Technology 19.65%
3 Industrials 9.92%
4 Materials 8.09%
5 Consumer Staples 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CI icon
1
Cigna
CI
$75.8B
$547M 13.69%
2,076,189
+480,192
+30% +$124M
THC icon
2
Tenet Healthcare
THC
$20.6B
$359M 8.97%
6,825,671
+444,628
+7% +$30.9M
GPN icon
3
Global Payments
GPN
$21.4B
$260M 6.51%
2,352,712
-3,600
-0.2% -$455K
DXC icon
4
DXC Technology
DXC
$1.53B
$240M 6.01%
7,923,704
+374,693
+5% +$11.6M
MCK icon
5
McKesson
MCK
$96.9B
$237M 5.92%
725,839
-210,202
-22% -$67.3M
FISV
6
Fiserv Inc
FISV
$26.8B
$191M 4.77%
2,142,801
CCEP icon
7
Coca-Cola Europacific Partners
CCEP
$46.1B
$166M 4.14%
3,210,186
+363,990
+13% +$18.6M
USFD icon
8
US Foods
USFD
$21.2B
$142M 3.55%
4,624,862
+204,995
+5% +$6.93M
BAX icon
9
Baxter International
BAX
$11.3B
$140M 3.49%
2,173,019
-38,017
-2% -$2.76M
APTV icon
10
Aptiv
APTV
$11.9B
$133M 3.32%
1,489,959
+389,773
+35% +$39.8M
CHNG
11
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$99.8M 2.5%
4,328,222
+1,743,407
+67% +$40.7M
CNC icon
12
Centene
CNC
$31.5B
$90.8M 2.27%
1,073,420
-20,000
-2% -$1.66M
UBER icon
13
Uber
UBER
$141B
$87.8M 2.2%
4,289,342
+452,757
+12% +$12M
CTVA icon
14
Corteva
CTVA
$59.2B
$84.5M 2.12%
1,561,646
+32,466
+2% +$1.88M
DD icon
15
DuPont de Nemours
DD
$18.6B
$83.6M 2.09%
1,197,791
-31,866
-3% -$2.61M
FMC icon
16
FMC
FMC
$1.46B
$81.2M 2.03%
758,499
+401,978
+113% +$49.1M
EHC icon
17
Encompass Health
EHC
$11.4B
$77M 1.93%
1,727,435
+111,519
+7% +$5.72M
AMZN icon
18
Amazon
AMZN
$2.51T
$76M 1.9%
715,164
-104,076
-13% -$13M
ESI icon
19
Element Solutions
ESI
$9.39B
$74.2M 1.86%
4,166,904
+1,100,000
+36% +$22.3M
VVV icon
20
Valvoline
VVV
$4.88B
$57.6M 1.44%
1,996,539
+251,969
+14% +$7.74M
NSC icon
21
Norfolk Southern
NSC
$78.1B
$56.9M 1.42%
250,479
+88,601
+55% +$21.8M
HCA icon
22
HCA Healthcare
HCA
$85.5B
$53.2M 1.33%
316,829
MSFT icon
23
Microsoft
MSFT
$2.86T
$52.8M 1.32%
+205,392
New +$55.7M
CI icon
24
CALL
Cigna
CI
$75.8B
$52.7M 1.32%
200,000
+100,000
+100% +$25.8M
LGV.U
25
DELISTED
Longview Acquisition Corp. II Units, each consisting of one share of Class A Common Stock and one-fifth of one redeemable Warrant
LGV.U
$49M 1.23%
5,000,000

Similar funds

Glenview Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Glenview Capital Management held 66 positions worth $4B, down 19% from $4.94B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Glenview Capital Management withdrew a net $186M in Q2 2022, closing 11 positions and reducing 16 holdings. Its most notable exit was Bausch Health, an estimated $212M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 49% a quarter earlier, followed by Technology and Industrials.

Against the trend, Glenview Capital Management opened a new position in Microsoft worth $52.8M.

  • Glenview Capital Management's largest Q2 2022 buy was Microsoft: 205,392 shares worth $52.8M.
  • Glenview Capital Management added most to Cigna in Q2 2022, an estimated $124M increase.
  • Glenview Capital Management's biggest Q2 2022 reduction was McKesson, cutting an estimated $67.3M.
  • Glenview Capital Management fully exited Bausch Health in Q2 2022, selling an estimated $212M.
  • Glenview Capital Management's ten largest holdings make up 60% of its $4B portfolio in Q2 2022.
  • Glenview Capital Management opened 6 new positions and closed 11 in Q2 2022.
  • Glenview Capital Management's portfolio value fell 19% quarter-over-quarter to $4B.

Based on Glenview Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.